Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis

Published:2017-04-20 Issue:30 Volume:8 Page:50034-50050
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tang Jingyuan¹²,Qin Zhiqiang¹,Li Xiao³,Han Peng¹,Wang Feng⁴,Yang Chengdi¹,Li Ran¹,Wang Kunpeng¹⁵,Tang Min¹,Wang Wei¹,Lv Qiang¹,Zhang Wei¹

Affiliation:

1. Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China

2. Department of Urology, Wuxi Second People's Hospital, Nanjing Medical University, Wuxi, 214002, China

3. Department of Urologic Surgery, The Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, 210029, China

4. Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China

5. Department of Urology, The First People's Hospital of Lianyungang City, Lianyungang, 222002, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis;Meta Gene;2022-02

2. Primary Adenocarcinoma of Lung with Synchronous Renal Cell Carcinoma: A Case Report and Review of the Literature;International Journal of Cancer Management;2020-11-24

3. Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population;African Journal of Urology;2020-09-30

4. Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models;International Journal of Molecular Sciences;2020-02-18

5. Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF);Journal of Thoracic Disease;2019-09